We are live on ! Find out more
SP

SIH Partners Portfolio holdings

AUM $7.58B
1-Year Est. Return 5.28%
This Fund
S&P 500
This Quarter Est. Return
+1.62%
1 Year Est. Return
+5.28%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.69B
AUM Growth
-$263M
Cap. Flow
-$386M
Cap. Flow %
-14.36%
Top 10 Hldgs %
65.93%
Holding
325
New
55
Increased
42
Reduced
42
Closed
171

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$127M
2
JD icon
JD.com
JD
+$62.9M
3
AMRZ
Amrize Ltd
AMRZ
+$50.6M
4
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$45M
5
LI icon
Li Auto
LI
+$25M

Top Sells

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$127M
2
UBS icon
UBS Group
UBS
+$114M
3
STLA icon
Stellantis
STLA
+$55.8M
4
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$28.1M
5
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$24.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 20.42%
2 Materials 3.76%
3 Communication Services 3.25%
4 Technology 1.63%
5 Healthcare 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRYS icon
251
Krystal Biotech
KRYS
$9.88B
– –
-1,815
Closed -$327K
LLY icon
252
Eli Lilly
LLY
$1.07T
– –
-15,297
Closed -$12.6M
LXRX icon
253
Lexicon Pharmaceuticals
LXRX
$1.02B
– –
-23,712
Closed -$10.9K
MCK icon
254
McKesson
MCK
$98.5B
– –
-1,404
Closed -$945K
MDGL icon
255
Madrigal Pharmaceuticals
MDGL
$12.6B
– –
-1,391
Closed -$461K
MEDP icon
256
Medpace
MEDP
$16.8B
– –
-1,907
Closed -$581K
MNKD icon
257
MannKind Corp
MNKD
$1.28B
– –
-19,132
Closed -$96.2K
MRK icon
258
Merck
MRK
$324B
– –
-23,887
Closed -$2.14M
MRNA icon
259
Moderna
MRNA
$21.5B
– –
-36,846
Closed -$1.04M
MSTR icon
260
Strategy Inc
MSTR
$33.5B
– –
-13,560
Closed -$3.91M
MT icon
261
CALL
ArcelorMittal
MT
$50.4B
– –
-1,180,400
Closed -$34.1M
MT icon
262
PUT
ArcelorMittal
MT
$50.4B
– –
-1,047,800
Closed -$30.2M
MTD icon
263
Mettler-Toledo International
MTD
$26.8B
– –
-190
Closed -$224K
MU icon
264
Micron Technology
MU
$1.04T
– –
-30,320
Closed -$2.63M
NGD
265
DELISTED
New Gold Inc
NGD
– –
-13,895
Closed -$51.5K
NTLA icon
266
Intellia Therapeutics
NTLA
$1.5B
– –
-13,406
Closed -$95.3K
NUVL
267
DELISTED
Nuvalent
NUVL
– –
-4,169
Closed -$296K
NXE icon
268
NexGen Energy
NXE
$6.05B
– –
-15,313
Closed -$68.8K
PACB icon
269
Pacific Biosciences
PACB
$422M
– –
-91,128
Closed -$108K
PCVX icon
270
Vaxcyte
PCVX
$7.89B
– –
-8,109
Closed -$306K
PFE icon
271
Pfizer
PFE
$140B
– –
-108,165
Closed -$2.74M
PGEN icon
272
Precigen
PGEN
$1.93B
– –
-19,203
Closed -$28.6K
PSNL icon
273
Personalis
PSNL
$1.26B
– –
-19,966
Closed -$70.1K
PTCT icon
274
PTC Therapeutics
PTCT
$6.37B
– –
-4,962
Closed -$253K
QFIN icon
275
Qfin Holdings
QFIN
$1.61B
– –
-53,800
Closed -$2.42M
9 10
11
12 13

Similar funds

OPERF
Oregon Public Employees Retirement Fund Tigard, Oregon $7.58B AUM 27.19% 1-Year Est. Return
AIM
Adapt Investment Managers Geneva, Switzerland $7.56B AUM 29.66% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return

SIH Partners's Q2 2025 Portfolio in Review

As of Q2 2025, SIH Partners held 325 positions worth $2.69B, down 8.9% from $2.95B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

SIH Partners withdrew a net $386M in Q2 2025, closing 171 positions and reducing 42 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $28.1M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 14% a quarter earlier, followed by Materials and Communication Services.

Against the trend, SIH Partners opened a new position in Amrize Ltd worth $49.7M.

  • SIH Partners's largest Q2 2025 buy was Amrize Ltd: 1,003,159 shares worth $49.7M.
  • SIH Partners added most to Alibaba in Q2 2025, an estimated $127M increase.
  • SIH Partners's biggest Q2 2025 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $127M.
  • SIH Partners fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q2 2025, selling an estimated $28.1M.
  • SIH Partners's ten largest holdings make up 66% of its $2.69B portfolio in Q2 2025.
  • SIH Partners opened 55 new positions and closed 171 in Q2 2025.
  • SIH Partners's portfolio value fell 8.9% quarter-over-quarter to $2.69B.

Based on SIH Partners's 13F filing for Q2 2025, filed 14 Aug 2025.